Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

1500012K07Rik Inhibitors

Chemical inhibitors of 1500012K07Rik can modulate the activity of this protein through various mechanisms by targeting different components of signaling pathways in which it is involved. Wortmannin and LY294002 are two such inhibitors that act on the phosphoinositide 3-kinases (PI3K), which form an integral part of the PI3K/AKT/mTOR pathway, upstream of 1500012K07Rik. By inhibiting PI3K, these chemicals lead to a reduced phosphorylation and subsequent activation of AKT, thereby indirectly inhibiting the function of 1500012K07Rik. Another molecule, Rapamycin, binds to FKBP12 and specifically inhibits the mammalian target of rapamycin (mTOR), another pivotal component of the same pathway. The inhibition of mTOR by Rapamycin results in a decrease in the functional activity of downstream proteins, including 1500012K07Rik.

In addition to the PI3K/AKT/mTOR pathway, 1500012K07Rik is also regulated by the MAPK/ERK and p38 MAP kinase pathways. U0126 and PD98059 are selective inhibitors of MEK1/2, which are upstream of ERK1/2 in the MAPK/ERK pathway. By inhibiting MEK1/2, these chemicals lead to a lower activation of ERK1/2 and thus reduce the functional activity of 1500012K07Rik. SB203580 is an inhibitor that targets p38 MAP kinase in the MAPK pathway, leading to the inhibition of downstream effects on 1500012K07Rik. Furthermore, SP600125 inhibits JNK, another kinase within the MAPK pathway, leading to reduced activity of proteins like 1500012K07Rik that are influenced by JNK signaling. Additional regulators of 1500012K07Rik include Gefitinib, Erlotinib, and Lapatinib, which are inhibitors of EGFR tyrosine kinase, an enzyme upstream of several signaling cascades involving 1500012K07Rik. By inhibiting EGFR, these chemicals prevent the activation of downstream pathways that regulate the function of 1500012K07Rik. Lastly, Sunitinib and Sorafenib act as multi-targeted receptor tyrosine kinase inhibitors, suppressing various kinases within signaling pathways and hence the activity of proteins such as 1500012K07Rik that lie downstream.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3K which is a component of the PI3K/AKT/mTOR pathway, a pathway that 1500012K07Rik is known to be involved in. Inhibition of PI3K leads to reduced AKT phosphorylation and activity, thereby functionally inhibiting the downstream effects on 1500012K07Rik.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A synthetic inhibitor of PI3K, leading to a decrease in AKT activation within the PI3K/AKT/mTOR pathway, which in turn results in functional inhibition of downstream proteins including 1500012K07Rik.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Binds to FKBP12 and inhibits mTOR, a key downstream component of the PI3K/AKT/mTOR pathway. Since 1500012K07Rik is part of this pathway, inhibition of mTOR leads to functional inhibition of 1500012K07Rik.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Selectively inhibits MEK1/2 which are upstream of ERK1/2 in the MAPK/ERK pathway. Since 1500012K07Rik is a downstream effector, inhibition of MEK1/2 results in reduced ERK activation and functional inhibition of 1500012K07Rik.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK1/2 in the MAPK/ERK pathway, leading to decreased ERK1/2 activity and thereby functionally inhibiting downstream proteins including 1500012K07Rik.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Selectively inhibits p38 MAP kinase within the MAPK pathway. As 1500012K07Rik functions downstream of this pathway, the inhibition of p38 MAP kinase leads to the functional inhibition of 1500012K07Rik.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, part of the MAPK pathway, leading to reduced activity of downstream proteins such as 1500012K07Rik.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Inhibits EGFR tyrosine kinase, which is upstream of several signaling pathways including the one involving 1500012K07Rik, thus functional inhibition of EGFR leads to inhibition of downstream effects on 1500012K07Rik.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Another EGFR tyrosine kinase inhibitor that prevents activation of downstream signaling pathways that include 1500012K07Rik, leading to its functional inhibition.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Inhibits the tyrosine kinases of HER2/neu and EGFR which are upstream of cellular pathways involving 1500012K07Rik, leading to functional inhibition of the protein.